| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EHC | Encompass Health Common Stock | Options Exercise | $467K | +16.1K | +26.64% | $29.06 | 76.4K | Apr 29, 2025 | Direct | |
| transaction | EHC | Encompass Health Common Stock | Options Exercise | $906K | +27.5K | +35.99% | $32.94 | 104K | Apr 29, 2025 | Direct | |
| transaction | EHC | Encompass Health Common Stock | Sale | -$3.01M | -26.2K | -25.25% | $114.78 | 77.7K | Apr 29, 2025 | Direct | F1 |
| transaction | EHC | Encompass Health Common Stock | Sale | -$1.55M | -13.4K | -17.25% | $115.51 | 64.3K | Apr 29, 2025 | Direct | F2 |
| transaction | EHC | Encompass Health Common Stock | Sale | -$458K | -3.93K | -6.12% | $116.36 | 60.3K | Apr 29, 2025 | Direct | F3 |
| holding | EHC | Encompass Health Common Stock | 126K | Apr 29, 2025 | By irrevocable trust for the benefit of children | ||||||
| holding | EHC | Encompass Health Common Stock | 65.2K | Apr 29, 2025 | By spouse | F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EHC | Non-qualified Stock Option (Right to Buy) | Options Exercise | $0 | -16.1K | -100% | $0.00 | 0 | Apr 29, 2025 | Encompass Health Common Stock | 16.1K | $29.06 | Direct | F5 |
| transaction | EHC | Non-qualified Stock Option (Right to Buy) | Options Exercise | $0 | -27.5K | -49.82% | $0.00 | 27.7K | Apr 29, 2025 | Encompass Health Common Stock | 27.5K | $32.94 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.22 to $115.21, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range. |
| F2 | This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.22 to $116.21, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range. |
| F3 | This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.22 to $116.57, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range. |
| F4 | The reporting person disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. |
| F5 | The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc. |